Surgical Management of Vascular anomalies

被引：0

作者：

Dasgupta R. ^{[1
]}

机构：

[1] Division of Pediatric General and Thoracic Surgery, Cincinnati Childrens Medical Center, 3333 Burnet Ave, ML2023, Cincinnati, 45229, OH

来源：

Current Otorhinolaryngology Reports | 2014年 / 2卷 / 4期

关键词：

Arteriovenous malformations; Hemangioma; Kaposiform hemangioendothelioma; Lymphatic malformation; Venous malformation;

D O I：

10.1007/s40136-014-0066-5

中图分类号：

学科分类号：

摘要：

Vascular anomalies have been historically divided into tumors and malformations based on the Mulliken and Glowacki classification system. Vascular malformations are also further subdivided into simple and combined based on vessel types. Surgical treatment has historically been the mainstay of treatment. With the advent of multi-disciplinary vascular anomaly clinics, the use of novel medical treatments, and the increased use of sclerotherapy, the role of surgery has been refined. Surgery is often now used in combination with other therapies and remains an integral tool for the management of the patient with vascular anomalies. © 2014, Springer Science+Business Media New York.

引用

页码：285 / 291

页数：6

共 41 条

[21]

Chiu Y.E., Drolet B.A., Blei F., Carcao M., Fangusaro J., Kelly M.E., Krol A., Lofgren S., Mancini A.J., Metry D.W., Recht M., Silverman R.A., Tom W.L., Pope E., Variable response to propranolol treatment of kaposiform hemangioendothelioma, tufted angioma, and Kasabach-Merritt phenomenon, Pediatr Blood Cancer, 59, pp. 934-938, (2012)

[22]

Blatt J., Stavas J., Moats-Staats B., Woosley J., Morrell D.S., Treatment of childhood kaposiform hemangioendothelioma with sirolimus, Pediatr Blood Cancer, 55, pp. 1396-1398, (2010)

[23]

Garcia-Monaco R., Giachetti A., Peralta O., Napoli N., Lobos P., Gioseffi L., Mariani G., Kaposiform hemangioendothelioma with Kasabach-Merritt phenomenon: successful treatment with embolization and vincristine in two newborns, J Vasc Interv Radiol, 23, pp. 417-422, (2012)

[24]

Brouillard P., Boon L., Vikkula M., Genetics of lymphatic anomalies, J Clin Invest, 124, pp. 898-904, (2014)

[25]

Marwan A., Crombleholme T.M., The EXIT procedure: principles, pitfalls, and progress, Semin Pediatr Surg, 15, pp. 107-115, (2006)

[26]

Olutoye O.O., Olutoye O.A., EXIT procedure for fetal neck masses, Curr Opin Pediatr, 24, pp. 386-393, (2012)

[27]

Emery P.J., Bailey C.M., Evans J.N., Cystic hygroma of the head and neck. A review of 37 cases, J Laryngol Otol, 98, pp. 613-619, (1984)

[28]

Kathary N., Bulas D.I., Newman K.D., Schonberg R.L., MRI imaging of fetal neck masses with airway compromise: utility in delivery planning, Pediatr Radiol, 31, pp. 727-731, (2001)

[29]

Hammill A.M., Wentzel M., Gupta A., Nelson S., Lucky A., Elluru R., Dasgupta R., Azizkhan R.G., Adams D.M., Sirolimus for the treatment of complicated vascular anomalies in children, Pediatr Blood Cancer, 57, pp. 1018-1024, (2011)

[30]

Renton J.P., Smith R.J., Current treatment paradigms in the management of lymphatic malformations, Laryngoscope, 121, pp. 56-59, (2011)

← 1 2 3 4 5 →